Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GPR160 pseudogene 2 (GPR160P2) is a non-coding genetic sequence annotated as a pseudogene related to the G protein-coupled receptor 160 gene family. By definition, pseudogenes such as GPR160P2 do not produce functional proteins and are not considered drug targets or mediators of physiological function[2][5]. The functional GPR160 gene encodes an orphan G protein-coupled receptor with possible roles in embryonic development, neuropathic pain perception, and oncology, but these characteristics do not apply to its pseudogene variant[1][3]. No disease associations, biological functions, or drug relationships have been reported for GPR160P2. In summary, GPR160P2 is a pseudogene and not a receptor or a therapeutic target, and any reference to it as a biologically active molecule or drug target is incorrect[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GPR160 pseudogene 2 (GPR160P2).